Cantor Fitzgerald’s Grace Therapeutics GRCE Stock Holding History
Bought
Maintained
Sold
Other funds holding GRCE
OM
Cantor Fitzgerald's GRCE Position: Q3 2026 in Review
Cantor Fitzgerald held its Grace Therapeutics (GRCE) position steady in Q3 2026 at 100,000 shares worth $215K. The position accounts for ﹤0.01% of the portfolio, ranked #602.
Cantor Fitzgerald first reported a position in GRCE in Q2 2026 and has held it in 2 quarters since. The position peaked at $227K in Q2 2026. 38 funds tracked by Wall St. Rank hold GRCE as of Q3 2026.
- Cantor Fitzgerald held 100,000 shares of Grace Therapeutics worth $215K as of Q3 2026.
- Cantor Fitzgerald left its Grace Therapeutics share count unchanged in Q3 2026.
- Grace Therapeutics made up ﹤0.01% of Cantor Fitzgerald's portfolio in Q3 2026, its #602 holding.
- Cantor Fitzgerald first reported a position in Grace Therapeutics in Q2 2026 and has held it in 2 quarters since.
- Cantor Fitzgerald's Grace Therapeutics position peaked at $227K in Q2 2026.
- 38 funds tracked by Wall St. Rank held Grace Therapeutics as of Q3 2026.
Based on Cantor Fitzgerald's 13F filing for Q3 2026, filed 16 Nov 2026.